12/12
10:09 am
aplt
Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating.
Low
Report
Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating.
12/12
08:36 am
aplt
Applied Therapeutics downgraded to Neutral from Outperform at Baird
High
Report
Applied Therapeutics downgraded to Neutral from Outperform at Baird
12/12
08:36 am
aplt
Applied Therapeutics downgraded to Neutral from Outperform at Baird
High
Report
Applied Therapeutics downgraded to Neutral from Outperform at Baird
12/3
08:46 am
aplt
Rating for APLT
Low
Report
Rating for APLT
12/3
08:44 am
aplt
Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $1.00 price target on the stock.
Low
Report
Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $1.00 price target on the stock.
12/3
06:36 am
aplt
Applied Therapeutics downgraded to Market Perform from Outperform at Leerink
Medium
Report
Applied Therapeutics downgraded to Market Perform from Outperform at Leerink
12/3
06:36 am
aplt
Applied Therapeutics downgraded to Market Perform from Outperform at Leerink
Medium
Report
Applied Therapeutics downgraded to Market Perform from Outperform at Leerink